Invention Grant
- Patent Title: Extracorporeal shockwave lithotripsy (ESWL) system and method using in-situ sensing of system and device data and therapeutic/system/device level control
-
Application No.: US15845296Application Date: 2017-12-18
-
Publication No.: US10820919B2Publication Date: 2020-11-03
- Inventor: Andrew James Griffis , Christopher Mark Gleason
- Applicant: Translational Technologies, LLC
- Applicant Address: US AZ Tucson
- Assignee: TRANSLATIONAL TECHNOLOGIES, LLC
- Current Assignee: TRANSLATIONAL TECHNOLOGIES, LLC
- Current Assignee Address: US AZ Tucson
- Agency: Grossman, Tucker, Perreault & Pfleger, PLLC
- Main IPC: A61B17/225
- IPC: A61B17/225 ; A61B34/10 ; A61B90/00 ; A61B17/00 ; A61B18/00 ; A61B34/00 ; H03K3/55

Abstract:
The present invention provides enhanced ESWL efficacy for therapeutic and operational outcomes. Device behavior and performance data is measured in-situ and analyzed for both intra-procedure and inter-procedure breadth of regard such that both therapy optimization and maintenance optimization engines are provided an accurate and current assessment of ESWL system and device state and performance. This feedback and control provides the ability to compensate in real time for the current patient therapy and offline for future patient therapy for machine/therapy idiosyncrasies and realize continuous calibration of system/devices to the performance required for maximum ESWL patient efficacy.
Public/Granted literature
Information query